Clinical impact and cost-effectiveness of the updated COVID-19 mRNA Autumn 2023 vaccines in Germany-Reference-Cited by-同舟云学术

Clinical impact and cost-effectiveness of the updated COVID-19 mRNA Autumn 2023 vaccines in Germany

Published:2023-12-13 Issue:1 Volume:27 Page:39-50
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Joshi Keya¹,Scholz Stefan²,Maschio Michael³,Kohli Michele³,Lee Amy³,Fust Kelly³,Ultsch Bernhard²,Van de Velde Nicolas¹,Beck Ekkehard¹

Affiliation:

1. Moderna, Inc., Cambridge, MA, USA

2. Moderna Germany GmbH, Munich, Germany

3. Quadrant Health Economics Inc, Cambridge, ON, Canada

Funder

Moderna

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2023.2290388

Reference67 articles.

1. UN. WHO chief declares end to COVID-19 as a global health emergency United Nations. 2023 [cited 2023 Sept 13]. https://news.un.org/en/story/2023/05/1136367.

2. RKI. COVID-19-Todesfälle in Deutschland. Berlin, Germany: Robert Koch Institute; 2023.

3. RKI. Decision on the implementation of the COVID-19 vaccination into the general recommendations of the STIKO 2023. Berlin, Germany; Robert Koch Institute; 2023.

4. Beschluss und wissenschaftliche begründung der ständigen impfkommission (STIKO) für die COVID-19-Impfempfehlung;Vygen-Bonnet S;Epidemiol Bull,2021

5. Empfehlung der STIKO zur implementierung der COVID-19-Impfung in die empfehlungen der STIKO 2023 und die dazugehörige wissenschaftliche begründung;Koch J;Epidemiol Bull,2023

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A descriptive review on the real-world impact of Moderna, inc. COVID-19 vaccines;Expert Review of Vaccines;2024-09-13